Search Results - "Hakamy, Sahar"

Diagnostic Discrepancies Between Intraoperative Frozen Section and Permanent Histopathological Diagnosis of Brain Tumors by Kurdi, Maher, Baeesa, Saleh, Maghrabi, Yazid, Bardeesi, Anas, Saeedi, Rothaina, Al-Sinani, Taghreed, Samkari, Alaa, Lary, Ahmed, Hakamy, Sahar

“…Intraoperative frozen section (IOFS) diagnosis of brain tumors plays an important role in assessing the adequacy of the sample and determining the treatment…”
Get full text

Immunolocalization of neurokinin 1 receptor in WHO grade 4 astrocytomas, oral squamous cell and urothelial carcinoma by Mehboob, Riffat, Kurdi, Maher, Baeesa, Saleh, Fawzy Halawa, Taher, Tanvir, Imrana, Maghrabi, Yazid, Hakamy, Sahar, Saeedi, Rothaina, Moshref, Rana, Nasief, Hisham, Hassan, Amber, Waseem, Humaira, Rasool, Shahida, Bahakeem, Basem, Faizo, Eyad, Katib, Yousef, Bamaga, Ahmed, Aldardeir, Nashwa

“…Introduction Neurokinin-1 receptor (NK-1R) induces inflammatory reactions in peripheral tissues but its regulatory effects in target tissues is dependent on…”
Get full text

Assessment of prognostic value of tissue inhibitors of metalloproteinase 3 (TIMP3) protein in ovarian cancer by Hakamy, Sahar, Assidi, Mourad, Jafri, Mohammad A., Nedjadi, Taoufik, Alkhatabi, Heba, Al-Qahtani, Abrar, Al-Maghrabi, Jaudah, Sait, Khalid, Al-Qahtani, Mohammed, Buhmeida, Abdelbaset, Chaudhary, Adeel

“…Background: TIMP3 is a multifunctional proteolytic enzyme belonging to TIMPs family and acts as a potent inhibitor of matrix metalloproteinases (MMPs). TIMP3…”
Get full text

Can oligodendrocyte transcriptional factor-2 (Olig2) be used as an alternative for 1p/19q co-deletions to distinguish oligodendrogliomas from other glial neoplasms? by Kurdi, Maher, Alkhatabi, Heba, Butt, Nadeem, Albayjani, Hameedah, Aljhdali, Hessa, Mohamed, Fawaz, Alsinani, Taghreed, Baeesa, Saleh, Almuhaini, Eman, Al-Ghafari, Ayat, Hakamy, Sahar, Faizo, Eyad, Bahakeem, Basem

“…Aim of the study Oligodendrocyte transcriptional factor-2 (Olig2) is an essential marker for oligodendrocytes expression. We aimed to explore the expression of…”
Get full text

Comprehensive Analysis of Genes Associated With Sudden Infant Death Syndrome by Mehboob, Riffat, Kurdi, Maher, Ahmad, Mursleen, Gilani, Syed Amir, Khalid, Sidra, Nasief, Hisham, Mirdad, Abeer, Malibary, Husam, Hakamy, Sahar, Hassan, Amber, Alaifan, Meshari, Bamaga, Ahmed, Shahzad, Syed Adnan

“…Background: Sudden infant death syndrome (SIDS) is a tragic incident which remains a mystery even after post-mortem investigation and thorough researches…”
Get full text

The Potential Effect of the IDH1 Mutation and MGMT Gene Promoter Methylation on the Control of Glioblastoma-Associated Epilepsy in Patients Receiving Anti-Epileptic Agents and Chemotherapies by Kurdi, Maher, Butt, Nadeem Shafique, Baeesa, Saleh, Alghamdi, Badrah, Maghrabi, Yazid, Bardeesi, Anas, Saeedi, Rothaina, Alghamdi, Fahad, Alghanmi, Najla, Bari, Mohammed, Samkari, Alaa, Lary, Ahmed, Alsinani, Taghreed, Hakamy, Sahar

“…Amaç: (a) Total rezeksiyondan sonra anti-epileptik ilaçlar ve kemoterapi alan glioblastom hastalarında nöbet kontrolünü, ve bunun…”
Get full text

Adult-type dermatomyositis with secondary lymphoid follicles harbouring reactive B-cells component by Maghrabi, Yazid, Hakamy, Sahar, Bahabri, Nizar, AlSobaei, Mohammed, Abuzinadah, Ahmad R., Kurdi, Maher

“…•Dermatomyositis is an autoimmune disease characterized by lesions in skin and inflammatory infiltrates of the muscle.•Its association with ectopic lymphoid…”
Get full text

Dynamic interplay between corticosteroid treatment and the role of SRC-1 gene dysregulation in the progression of WHO-Grade 4 Astrocytoma by Kurdi, Maher, Fadul, Motaz M, Addas, Bassam M. J., Faizo, Eyad, Alkhayyat, Shadi, Bamaga, Ahmed K., Alsinani, Taghreed, Katib, Yousef, Okal, Fahad, Maghrabi, Yazid, Sabbagh, Abdulrahman J., Moshref, Rana, Albalawi, Sultan, Alkhotani, Alaa, Halawa, Taher F., Mulla, Nasser, Hakamy, Sahar, Baeesa, Saleh

“…Background Corticosteroid is commonly used before surgery to control cerebral oedema in brain tumours and is frequently continued throughout treatment. Its…”
Get full text

The Diagnostic Value of Pan-Trk Expression to Detect Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion in CNS Tumours: A Study Using Next-Generation Sequencing Platform by Mohamed, Fawaz, Kurdi, Maher, Baeesa, Saleh, Sabbagh, Abdulrahman Jafar, Hakamy, Sahar, Maghrabi, Yazid, Alshedokhi, Mohammed, Dallol, Ashraf, Halawa, Taher F, Najjar, Ahmed A, Fdl-Elmula, Imad

“…Neurotrophic tyrosine receptor kinase ( ) fusion has been detected in rare types of CNS tumours, which can promote tumorigenesis. The efficacy of Trk inhibitor…”
Get full text

Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors by Kurdi, Maher, Mulla, Nasser, Malibary, Husam, Bamaga, Ahmed K, Fadul, Motaz M, Faizo, Eyad, Hakamy, Sahar, Baeesa, Saleh

“…Medulloblastoma (MB) is considered the commonest malignant brain tumor in children. Multimodal treatments consisting of surgery, radiation, and chemotherapy…”
Get full text

Major Histocompatibility Class-I (MHC-I) downregulation in glioblastoma is a poor prognostic factor but not a predictive indicator for treatment failure by Butt, Nadeem S., Kurdi, Maher, Fadul, Motaz M., Hakamy, Sahar, Addas, Bassam M.J., Faizo, Eyad, Alkhayyat, Shadi, Bamaga, Ahmed K., Alsinani, Taghreed, Katib, Yousef, Okal, Fahad, Maghrabi, Yazid, Sabbagh, Abdulrahman J., Moshref, Rana, Albalawi, Sultan, Alkhotani, Alaa, Mohammed, Fawaz, Mulla, Nasser, Baeesa, Saleh

“…BACKGROUNDMHC-I expression is a crucial factor in cancer immunity, and its regulations can impact tumor progression and recurrence. The mechanism through which…”
Get full text

Sensitivity Assessment of Wilms Tumor Gene Expression in Glioblastoma using qPCR and Immunohistochemistry and its Association with IDHI Mutation and Recurrence Interval by Kurdi, Maher, Butt, Nadeem Shafique, Baeesa, Saleh, Kuerban, Abudukadeer, Maghrabi, Yazid, Bardeesi, Anas, Saeedi, Rothaina, Alghamdi, Badrah S, Lary, Ahmed I, Mohamed, Fawaz, Hakamy, Sahar

“…Purpose: Wilms tumor 1 (WTI) gene has recently shown a role in gliomagenesis, making it a potential immunotherapy target in glioblastomas. We aimed to…”
Get full text

Association Between CD204-Expressed Tumor-Associated Macrophages and MGMT -Promoter Methylation in the Microenvironment of Grade 4 Astrocytomas by Kurdi, Maher, Katib, Yousef, Faizo, Eyad, Bahakeem, Basem, Alkhotani, Alaa, Alkhayyat, Shadi, Najjar, Ahmed A., Mehboob, Riffat, Halawa, Taher F., Addas, Bassam M.J., Albriky, Koloud, Hakamy, Sahar

Get full text

The Assessment of Major Histocompatibility Complex by Bamaga, Ahmed K, Alrawaili, Moafaq S, Fadel, Zahir T, Abuzinadah, Ahmad R, Kurdi, Maher, Butt, Nadeem Shafique, Hakamy, Sahar, Mohamed, Fawaz, Addas, Bassam MJ, Alshareef, Aysha

“…Background: Major histocompatibility complex (MHC) class-1 antigen is a glycoprotein expressed in all nucleated cells. The aim of this study was to assess MHC…”
Get full text

The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment by Kurdi, Maher, Mulla, Nasser, Katib, Yousef, Alsinani, Taghreed, Hakamy, Sahar, Mj Addas, Bassam, Malibary, Husam, Halawa, Taher F, S Farhan, Marwa, Faizo, Eyad, Baeesa, Saleh

“…IDH1 and IDH2 are hotspot mutations commonly identified in WHO-grade 4 astrocytomas. Their association with TAMs has never been investigated. We aim to explore…”
Get full text

Sensitivity Assessment of Wilms Tumor Gene (WT1) Expression in Glioblastoma using qPCR and Immunohistochemistry and its Association with IDH1 Mutation and Recurrence Interval by Kurdi, Maher, Butt, Nadeem Shafique, Baeesa, Saleh, Kuerban, Abudukadeer, Maghrabi, Yazid, Bardeesi, Anas, Saeedi, Rothaina, Alghamdi, Badrah S, Lary, Ahmed I, Mohamed, Fawaz, Hakamy, Sahar

“…Purpose: Wilms tumor 1 (WT1) gene has recently shown a role in gliomagenesis, making it a potential immunotherapy target in glioblastomas. We aimed to…”
Get full text

The Assessment of Major Histocompatibility Complex (MHC) Class-I Expression in Different Neuromuscular Diseases by Kurdi, Maher, Alshareef, Aysha, Bamaga, Ahmed K, Fadel, Zahir T, Alrawaili, Moafaq S, Hakamy, Sahar, Mohamed, Fawaz, Abuzinadah, Ahmad R, Addas, Bassam M J, Butt, Nadeem Shafique

“…Major histocompatibility complex (MHC) class-1 antigen is a glycoprotein expressed in all nucleated cells. The aim of this study was to assess MHC class-I…”
Get full text

Prognostic significance of fibroblast growth factor 19 (FGF19) expression in breast invasive ductal carcinoma by Hakamy, Sahar, Abdallah, Basmat, Buhmeida, Abdelbaset, Dallol, Ashraf, Merdad, Adnan, Al-Maghrabi, Jaudah, Abu-Elmagd, Muhammad, Gari, Mamdooh, Chaudhary, Adeel, Abuzenadah, Adel, Nedjadi, Taoufik, Ermiah, Eramah, Thubaity, Fatima, Al-Qahtani, Mohammed

“…Doc number: P35…”
Get full text

Can oligodendrocyte transcriptional factor-2 (Olig2) be used as an alternative for 1p/19q co-deletions to distinguish oligodendrogliomas from other glial neoplasms? by Kurdi, Maher, Alkhatabi, Heba, Butt, Nadeem, Albayjani, Hameedah, Aljhdali, Hessa, Mohamed, Fawaz, Alsinani, Taghreed, Baeesa, Saleh, Almuhaini, Eman, Al-Ghafari, Ayat, Hakamy, Sahar, Faizo, Eyad, Bahakeem, Basem

“…Oligodendrocyte transcriptional factor-2 (Olig2) is an essential marker for oligodendrocytes expression. We aimed to explore the expression of Olig2 in…”
Get more information

Adult-type dermatomyositis with secondary lymphoid follicles harbouring reactive B-cells component by Maghrabi, Yazid, Hakamy, Sahar, Bahabri, Nizar, AlSobaei, Mohammed, Abuzinadah, Ahmad R, Kurdi, Maher

Get full text